LB
FLNA

Leo Brokerage’s Filana Therapeutics FLNA Stock Holding History

Leo Brokerage’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$290K Buy
4,675
+675
+17% +$56.3K 0.05% 148
2021
Q2 		$342K Buy
+4,000
New +$214K 0.07% 140

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Leo Brokerage's FLNA Position: Q3 2021 in Review

Leo Brokerage increased its Filana Therapeutics (FLNA) stake by 17% in Q3 2021, buying an estimated $56.3K and bringing the position to 4,675 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #148.

Leo Brokerage first reported a position in FLNA in Q2 2021 and has held it in 2 quarters since. The position peaked at $342K in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

  • Leo Brokerage held 4,675 shares of Filana Therapeutics worth $290K as of Q3 2021.
  • Leo Brokerage bought 675 Filana Therapeutics shares in Q3 2021, an estimated $56.3K.
  • Filana Therapeutics made up 0.05% of Leo Brokerage's portfolio in Q3 2021, its #148 holding.
  • Leo Brokerage first reported a position in Filana Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • Leo Brokerage's Filana Therapeutics position peaked at $342K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on Leo Brokerage's 13F filing for Q3 2021, filed 13 Oct 2021.